Beranda › Kanker (semua jenis) › Hawaii
Uji klinis Kanker (semua jenis) di Hawaii
13 studi untuk Kanker (semua jenis) mencari peserta di lokasi di Hawaii.
Kota di Hawaii
Teks studi resmi (Bahasa Inggris)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Invision, LLC, Honolulu
- University of Hawaii Cancer Center, Honolulu
- Cardiology Associates, Inc, ‘Aiea
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06989437A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
- Kaiser Permanente Moanalua Medical Center /ID# 238363, Honolulu
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04928846TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- The Queen's Medical Center - POB I, Honolulu
- The Queen's Medical Center - Punchbowl, Honolulu
- The Queen's Medical Center - Kuakini, Honolulu
- dan 1 lainnya
Menerima pesertaFase 2
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT02693535Connect for Cancer Prevention Study (Connect)
- Kaiser Permanente Hawaii, Honolulu
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 70 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04609072RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Hawaii Pacific Neuroscience, Honolulu
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer
- Univercity of Hawaii Cancer Center, Honolulu
Menerima pesertaStudi observasional
Usia 40 ke atas · Wanita · Diperbarui 10 Sep 2026 · NCT06672302Project: Every Child for Younger Patients With Cancer
- Kapiolani Medical Center for Women and Children, Honolulu
Menerima pesertaStudi observasional
Hingga usia 25 · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT02402244Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu
- Queen's Cancer Cenrer - POB I, Honolulu
- Queen's Medical Center, Honolulu
- dan 11 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT06580314EXoPERT EMERALD Clinical Study
- University of Hawaii Cancer Center, Honolulu
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 45 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT07186296A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
- Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Jun 2026 · NCT07005102Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- Spark M. Matsunaga VA Medical Center, Honolulu
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
- Hilo Benioff Medical Center, Hilo
- Univesity of Hawaii Cancer Center, Honolulu
- Wilcox Medical Center, Lihue
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Apr 2026 · NCT06237816GEMINI-NSCLC: NSCLC Biomarker Study
- Hawaii Cancer Care, Honolulu
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05236114Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.